Paper · 23472829
2564 resected periampullary adenocarcinomas at a single institution: trends over three decades.
He J and 8 others. HPB (Oxford), 2014. Cited by 237 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. 2564 resected periampullary adenocarcinomas at a single institution: trends over three decades. Papers, record 23472829. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/23472829
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- 2564 resected periampullary adenocarcinomas at a single institution: trends over three decades.
- PubMed
Topics19
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Adenocarcinoma | Major topic |
| Bile Duct Neoplasms | Major topic |
| Duodenal Neoplasms | Major topic |
| Pancreatic Neoplasms | Major topic |
| Pancreaticoduodenectomy | Major topic |
| Adult | |
| Aged | |
| Aged, 80 and over | |
| Baltimore | |
| Female | |
| Humans | |
| Kaplan-Meier Estimate | |
| Male | |
| Middle Aged | |
| Proportional Hazards Models | |
| Retrospective Studies | |
| Risk Factors | |
| Time Factors | |
| Treatment Outcome |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| UL1 TR001079 | NCATS NIH HHS | United States | UL1TR001079 | PubMed and NIH |
Source NIH RePORTER
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References35
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 22,265,421 | Computational modeling of pancreatic cancer reveals kinetics of metastasis suggesting optimum treatment strategies. | Cell | 2012 | https://conductscience.org/library/papers/22265421 | PubMed |
| 2 | 22,895,392 | Guidelines for the diagnosis and treatment of cholangiocarcinoma: an update. | Gut | 2012 | https://conductscience.org/library/papers/22895392 | PubMed |
| 3 | 18,580,212 | Results of pancreaticoduodenectomy in patients with periampullary adenocarcinoma: perineural growth more important prognostic factor than tumor localization. | Ann Surg | 2008 | https://conductscience.org/library/papers/18580212 | PubMed |
| 4 | 22,167,476 | Duodenal adenocarcinoma: clinicopathologic analysis and implications for treatment. | Ann Surg Oncol | 2012 | https://conductscience.org/library/papers/22167476 | PubMed |
| 5 | 19,252,434 | Histopathologic features and microsatellite instability of cancers of the papilla of vater and their precursor lesions. | Am J Surg Pathol | 2009 | https://conductscience.org/library/papers/19252434 | PubMed |
| 6 | 15,549,428 | Pathogenesis of carcinoma of the papilla of Vater. | J Hepatobiliary Pancreat Surg | 2004 | https://conductscience.org/library/papers/15549428 | PubMed |
| 7 | 22,777,053 | Neither neoadjuvant nor adjuvant therapy increases survival after biliary tract cancer resection with wide negative margins. | J Gastrointest Surg | 2012 | https://conductscience.org/library/papers/22777053 | PubMed |
| 8 | 20,108,122 | Predictors of survival in periampullary cancers following pancreaticoduodenectomy. | Ann Surg Oncol | 2010 | https://conductscience.org/library/papers/20108122 | PubMed |
| 9 | 18,547,417 | Pancreatobiliary versus intestinal histologic type of differentiation is an independent prognostic factor in resected periampullary adenocarcinoma. | BMC Cancer | 2008 | https://conductscience.org/library/papers/18547417 | PubMed |
| 10 | 18,773,060 | Epidemiology, risk factors, and pathogenesis of cholangiocarcinoma. | HPB (Oxford) | 2008 | https://conductscience.org/library/papers/18773060 | PubMed |
1 to 10 of 35
See all 35 referencesCited by148
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 237 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,794,933 | Beyond Morphology: Molecular Evidence Supporting a Clonal Relationship Between Pancreatic Undifferentiated Carcinoma with Osteoclast-like Giant Cells (UCOGC) and Conventional Pancreatic Ductal Adenocarcinoma (PDAC). | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/42794933 | PubMed |
| 42,725,205 | Pancreaticoduodenectomy for ampullary adenocarcinoma performed in a conflict-zone field hospital during an active armed conflict: a case report. | Ann Med Surg (Lond) | 2026 | https://conductscience.org/library/papers/42725205 | PubMed |
| 42,548,877 | Single-cell RNA-seq and spatial transcriptomics characterize CD8+ exhausted T cells in pancreatic ductal adenocarcinoma. | iScience | 2026 | https://conductscience.org/library/papers/42548877 | PubMed |
| 42,464,359 | Robot-assisted versus open pancreatoduodenectomy for cancer in the pancreatic head (DIPLOMA-2x2): study protocol for an international multicentre patient- and assessor-blinded randomized controlled non-inferiority trial. | Trials | 2026 | https://conductscience.org/library/papers/42464359 | PubMed |
| 42,329,389 | Paired tumor-normal metabolomic profiling reveals alterations in choline phospholipid precursor metabolism in biliary tract cancer. | J Gastroenterol | 2026 | https://conductscience.org/library/papers/42329389 | PubMed |
| 42,262,476 | A case of small undifferentiated pancreatic carcinoma detected during follow-up for focal pancreatic parenchymal atrophy with fatty replacement. | Clin J Gastroenterol | 2026 | https://conductscience.org/library/papers/42262476 | PubMed |
| 41,651,953 | Association of computed tomography-derived body composition with surgical and oncologic outcomes in periampullary adenocarcinoma. | Surg Endosc | 2026 | https://conductscience.org/library/papers/41651953 | PubMed |
| 41,628,913 | Propensity score matched comparison of pancreatoduodenectomy with pancreatogastrostomy versus pancreatojejunostomy: A single institution experience shifting from pancreatogastrostomy to pancreatojejunostomy. | Ann Hepatobiliary Pancreat Surg | 2026 | https://conductscience.org/library/papers/41628913 | PubMed |
| 41,614,406 | Mechanistic insights into pancreatic cancer progression from circadian rhythm disruption and gut microbiota dysbiosis (Review). | Int J Mol Med | 2026 | https://conductscience.org/library/papers/41614406 | PubMed |
| 41,180,030 | Advanced intestinal-type ampullary cancer successfully treated using combination therapy with gemcitabine, cisplatin, and durvalumab: A case report. | SAGE Open Med Case Rep | 2025 | https://conductscience.org/library/papers/41180030 | PubMed |
1 to 10 of 148
See all 148 cited byGenes0
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
None in this release.
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/23472829
GET https://conductscience.org/api/papers/v1/23472829/references?page=2